Grand Zachary, Greer Klaudia, Brutti Jonathan, Ciesla Christopher, Rockwell Mikaela, Shae Jillian, Rasmussen Janae, Frye Payton
Medicine, Florida International University Herbert Wertheim College of Medicine, Miami, USA.
Orthopedic Surgery, Valley Consortium for Medical Education, Modesto, USA.
Cureus. 2025 Jul 25;17(7):e88733. doi: 10.7759/cureus.88733. eCollection 2025 Jul.
Extracellular matrix (ECM) and amniotic derivatives have emerged as promising biomaterials in regenerative medicine, particularly for bone and nerve repair. These biologic scaffolds provide structural and biochemical cues that support cellular migration, proliferation, and differentiation, thereby facilitating tissue regeneration. ECM-based therapies leverage native bioactive components to modulate immune responses and enhance healing, while perinatal derivatives, including amniotic membrane, umbilical cord, and placental tissue, offer a rich source of growth factors, cytokines, and stem cells that promote neurogenesis and osteogenesis. This literature review explores the mechanistic underpinnings of ECM and perinatal derivatives in bone and nerve repair, detailing their role in cellular signaling, inflammation modulation, and extracellular microenvironment remodeling. Furthermore, we discuss current preclinical and clinical applications, evaluating their efficacy in enhancing functional recovery in orthopedic and neurosurgical contexts. While these therapies hold immense potential, challenges like standardization, immunogenicity, and clinical translation remain key areas for future research. By integrating ECM and perinatal-based approaches, regenerative medicine can advance toward more effective, biologically driven solutions for complex bone and nerve injuries.
细胞外基质(ECM)和羊膜衍生物已成为再生医学中很有前景的生物材料,特别是用于骨修复和神经修复。这些生物支架提供结构和生化线索,支持细胞迁移、增殖和分化,从而促进组织再生。基于ECM的疗法利用天然生物活性成分来调节免疫反应并促进愈合,而围产期衍生物,包括羊膜、脐带和胎盘组织,提供了丰富的生长因子、细胞因子和干细胞来源,可促进神经发生和骨生成。这篇文献综述探讨了ECM和围产期衍生物在骨修复和神经修复中的作用机制,详细阐述了它们在细胞信号传导、炎症调节和细胞外微环境重塑中的作用。此外,我们讨论了当前的临床前和临床应用,评估了它们在骨科和神经外科环境中增强功能恢复的疗效。虽然这些疗法具有巨大潜力,但标准化、免疫原性和临床转化等挑战仍然是未来研究的关键领域。通过整合基于ECM和围产期的方法,再生医学可以朝着更有效、由生物驱动的复杂骨和神经损伤解决方案迈进。